| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CODEXIS, INC. | Director | Common Stock | 144K | $362K | $2.52 | Jun 10, 2025 | Direct |
| SANGAMO THERAPEUTICS, INC | Director | Common Stock | 113K | $51.8K | $0.46 | Jun 12, 2025 | Direct |
| IMPEL NEUROPHARMA INC | Director | Common Stock | 20.2K | $5.84K | $0.29 | Apr 27, 2021 | Direct |
| SANGAMO THERAPEUTICS, INC | Director | Stock Option (Right to Buy) | 50K | Jun 12, 2025 | Direct | ||
| IMPEL PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 12.8K | Jun 16, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SGMO | SANGAMO THERAPEUTICS, INC | Jun 12, 2025 | 2 | $0 | 4 | Jun 16, 2025 | Director |
| CDXS | CODEXIS, INC. | Jun 10, 2025 | 1 | $0 | 4 | Jun 12, 2025 | Director |
| CDXS | CODEXIS, INC. | Jun 11, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
| SGMO | SANGAMO THERAPEUTICS, INC | Jun 4, 2024 | 2 | $0 | 4 | Jun 6, 2024 | Director |
| CDXS | CODEXIS, INC. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| SGMO | SANGAMO THERAPEUTICS, INC | Jun 1, 2023 | 2 | $0 | 4 | Jun 5, 2023 | Director |
| CDXS | CODEXIS, INC. | Dec 16, 2022 | 1 | $0 | 4 | Dec 20, 2022 | Director |
| CDXS | CODEXIS, INC. | Dec 16, 2022 | 0 | $0 | 3 | Dec 20, 2022 | Director |
| IMPL | IMPEL PHARMACEUTICALS INC | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| SGMO | SANGAMO THERAPEUTICS, INC | Jun 1, 2022 | 1 | $18K | 4 | Jun 3, 2022 | Director |
| SGMO | SANGAMO THERAPEUTICS, INC | Feb 25, 2022 | 2 | $0 | 4 | Mar 1, 2022 | Director |
| IMPL | IMPEL NEUROPHARMA INC | Jul 11, 2021 | 1 | $0 | 4 | Jul 13, 2021 | Director |
| IMPL | IMPEL NEUROPHARMA INC | Apr 27, 2021 | 0 | $0 | 4/A | Jun 22, 2021 | Director |
| IMPL | IMPEL NEUROPHARMA INC | Apr 22, 2021 | 0 | $0 | 3/A | Jun 22, 2021 | Director |